Microalbuminuria, chronic renal disease, and the effects of the metabolic syndrome on cardiovascular events [0.03%]
微量白蛋白尿、慢性肾病以及代谢综合征对心血管事件的影响
Marvin Moser,James R Sowers,Henry R Black
Marvin Moser
In March 2007, a panel discussion was held following a hypertension symposium in New York, New York. The panel was moderated by Marvin Moser, MD, Clinical Professor of Medicine at the Yale University School of Medicine, New Haven, Connectic...
Javier Díez
Javier Díez
Changes in the composition of cardiac tissue develop in hypertensive patients with left ventricular hypertrophy (ie, hypertensive heart disease) and lead to structural remodeling of the myocardium. One of these changes is related to the dis...
Fasika Tedla,Rick Hayashi,Samy I McFarlane et al.
Fasika Tedla et al.
Hypertension is common after renal transplant and is associated with adverse graft and patient outcomes. A thorough understanding of the unique factors that operate in renal transplant recipients is essential for the proper evaluation and m...
Pioglitazone decreases ambulatory blood pressure in type 2 diabetics with difficult-to-control hypertension [0.03%]
吡格列酮可降低2型糖尿病伴难治性高血压患者的动态血压水平
Beatriz de Rivas,Manuel Luque,Nieves Martell et al.
Beatriz de Rivas et al.
Blood pressure (BP) control at recently established goals of or=125/75 mm Hg) taking antihypertensive medications (mean, 4.1+/-0.8 drugs) were enrolled in an open, prospective, blinded end point study of add-on therapy with pioglitazone 30 ...
Age-specific impact of self-monitored pulse pressure on hypertensive target organ damage in treated hypertensive patients [0.03%]
治疗高血压患者中自我监测的脉压对靶器官损害的年龄特异性影响
Kazuo Eguchi,Yoshio Matsui,Seiichi Shibasaki et al.
Kazuo Eguchi et al.
The authors examined the relationship of clinic and self-measured pulse pressure with target organ damage in 597 treated hypertensive patients without clinical evidence of renal dysfunction or a history of heart failure. The cross-sectional...
Feasibility, accuracy, and clinical relevance of a rapid thyroid evaluation during carotid duplex ultrasonography in hypertensive patients [0.03%]
高血压患者在颈动脉双功超声检查中快速评估甲状腺的可行性、精确性及临床意义
Francesco Natale,Michele Adolfo Tedesco,Rosa Mocerino et al.
Francesco Natale et al.
Carotid ultrasonography can detect thyroid nodules without increasing examination duration. The authors analyzed whether management is influenced by reporting such findings during routine carotid ultrasonography in hypertensive patients vs ...
Comparison of pulse wave analysis between persons with white coat hypertension and normotensive persons [0.03%]
白大衣高血压患者与正常血压患者的脉波分析比较研究
Neil J Wimmer,Kinji Sathi,Tiffany L Chen et al.
Neil J Wimmer et al.
White coat hypertension (WCH) is considered by some but not all investigators to be a benign condition without increased cardiovascular risk. Pulse wave analysis is a noninvasive method to measure how the reflected pressure wave interacts w...
Cardiovascular function in normotensive offspring of persons with essential hypertension and black race [0.03%]
原发性高血压患者正常血压后代的心血管功能及肤色的影响
Emile R Mohler rd,Kitty O&#x;Hare,Eduardo S Darze et al.
Emile R Mohler rd et al.
Prior investigations have shown impaired endothelial function in hypertensive blacks when compared with whites. It is not clear, however, whether the difference in vascular responsiveness predates or follows the development of hypertension....
The impact of plasma high-sensitivity C-reactive protein levels on cardiovascular risk stratification of hypertensive patients: results of the ICEBERG study [0.03%]
血浆高敏C-反应蛋白水平对高血压患者心血管风险分层的影响：ICEBERG研究结果
Omer Kozan,Kemalettin Buyukozturk,Baris Ilerigelen et al.
Omer Kozan et al.
The Intensive/Initial Cardiovascular Examination Regarding Blood Pressure Levels: Evaluation of Risk Groups (ICEBERG) study focused on the impact of high-sensitivity C-reactive protein (hs-CRP) measurement on cardiovascular risk evaluation....
Hypertensive patients with reduced blood pressure still have hypertension: the role of the hypertension specialist [0.03%]
血压下降的高血压患者仍然需要专科医生的治疗
Thomas D Giles
Thomas D Giles
“There is no good theory of disease which does not at once suggest a cure.”—Ralph Waldo Emerson